Skip to main content
Clinical Trials/NCT07240779
NCT07240779
Not yet recruiting
Not Applicable

Evaluating the Use of Advanced Sperm Selection Methods on ICSI Procedure Outcomes by Physiological Intracytoplasmic Sperm Injection (PICSI) Verses ZyMot Device

Sunrise Fertility Center0 sites300 target enrollmentStarted: November 15, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Sunrise Fertility Center
Enrollment
300
Primary Endpoint
Primary outcome measure

Overview

Brief Summary

our study explores the effectiveness of two advanced sperm selection techniques-PICSI and the ZyMot microfluidic device-in improving outcomes of Intracytoplasmic Sperm Injection (ICSI). It aims to compare their impact on fertilization rates, embryo quality, and clinical pregnancy success, helping determine which method offers superior results in assisted reproductive technology.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 39 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Primary outcome measure

Time Frame: 6-9 weeks after embryo transfer.

1• clinical pregnancy rate:- defined as the presence of a fetal heartbeat or gestational sac. • Unit of Measure: Percentage (%)

Secondary Outcomes

  • secondary outcome measure(1-After 6 weeks of gestation.)

Investigators

Sponsor
Sunrise Fertility Center
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials